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Humoral control of water and electrolyte excretion during water
restriction in sodium-deprived dogs. The goals of the present study were
twofold: first, to assess the renal excretory and hormonal responses to
chronic water restriction in dogs whose sodium retaining mechanisms
had been stimulated through dietary sodium (Na ) deprivation; second,
to determine the mediator(s) of the natriuresis which was observed with
water restriction in these sodium deprived dogs. Three groups of dogs
maintained on a low Na diet (5 mEq/day) for two weeks underwent a
three day period of water restriction. In normal, intact dogs Group I (N
= 5), water restriction resulted in a significant increase in Na
excretion with a net cumulative loss of 26.3 2.6 mEq over three days.
The natriuresis was associated with a significant increase in plasma
vasopressin (PAVP) (1.7 to 10.2 pg/mliter) and a significant fall in
plasma aldosterone (PALDO) from the levels observed with Na
restriction alone (24.9 to 12.4 ng/dliter). The natriuresis could not be
explained by decreases in food intake as determined by control studies
in four dogs. Group 2 (N = 6) dogs had a decrease in PALDO with
water restriction that was prevented by means of continuous iv.
aldosterone infusion (6.0 g/kgIday). Dogs in this group failed to
demonstrate a natriuresis during three days of water restriction, despite
the fact that PAVP rose from 3.3 0.8 to a peak level of 14.95 1.9
pglmliter. Group 3 (N = 6) dogs underwent selective neuro-
hypophysectomy. thus preventing the rise in PAVP during three days of
water restriction. In this group, PALDO also remained unchanged from
the Na deprived level during water restriction, and no natriuresis was
observed. We conclude: 1) that the natriuresis which occurs with water
restriction is a potent physiological response that occurs even in the
Na restricted state; and 2) this natriuresis can be explained by a fall in
PALDO and not the rise in PAVP.
resulted in significantly greater hypernatremia and hyperos-
molality after three days of water restriction.
It has not been possible to determine with any degree of
certainty the mechanisms responsible for the natriuresis, since
in most previous studies of water restriction, many of the major
neuroendocrine controllers of sodium excretion were not deter-
mined. Furthermore, the influence of the level of sodium intake
on the natriuresis of water restriction has not been assessed in
prior studies. This could be an important consideration since it
is clear that in both experimental and clinical states of dehydra-
tion, the solute/water ratio of ingested or intravenous fluids
could considerably influence the responses of the various homeo-
static controllers of plasma osmolality and sodium balance.
The objectives of the present study, therefore, were: I) to
sequence the renal, endocrine, and arterial pressure responses
to chronic water restriction in conscious, sodium—deprived
dogs. In so doing, we were able to assess whether the natri-
uretic response was sufficiently potent to overcome the strong
anti-natriuretic systems which had been activated through
dietary sodium deprivation; and 2) through selective manipula-
tion of various humoral factors, to determine the mechanism of
the natriuresis.
Methods
Animal preparation
Hypovolemic hypernatremia due to simple water restriction
is a common physiological occurrence and is frequently ob-
served in various clinical situations, such as with comatose
patients or patients with inadequate thirst mechanisms. Asso-
ciated with the hypernatremia of water restriction, an increase
in sodium excretion has been observed in a variety of animal
species [1—6]. It has been suggested recently [71 that this sodium
loss may contribute significantly to osmoregulation during
water restriction periods. McKinley et al 7] observed in sheep
maintained on a normal sodium intake that the natriuresis could
be prevented through prior ablation of tissue in the anterior wall
of the third cerebral ventricle. Prevention of the natriuresis
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Sixteen well—conditioned mongrel dogs (average wt = 17.8
0.5 kg) of either sex were used for these studies. Four of
these sixteen dogs underwent both experimental protocols 3
and 4 (outlined below). Dogs were anesthetized with sodium
pentobarbital (i.v. 30 mg/kg; Schien Inc., Port Washington,
New Jersey, USA) for implantation of arterial, venous and
bladder catheters. Polyvinyl catheters were introduced through
a femoral artery and placed in the abdominal aorta at a site
distal to the renal artery, and another was placed in the inferior
vena cava through the ipsilateral femoral vein. These were
tunneled subcutaneously to the intrascapular region of the back
where they emerged through the skin and were protected with
a canvas jacket. In eight of the dogs (Protocols 3 and 4) a
bladder cannula was implanted through a suprapubic midline
incision and brought directly through the adjacent abdominal
wall, as described previously [81.
Bicillin (Wyeth Laboratories. Philadelphia, Pennsylvania,
USA) was administered post-surgically (1.2 million units) and
thereafter dogs were given 250 to 500 mg Ampicillin (Schien
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Inc., Port Washington, New Jersey, USA) daily. At least ten to
14 days were allowed for recovery from surgery before any
experimental procedure was initiated.
In addition, six of the sixteen dogs (Protocol 4) also under-
went a selective neurohypophysectomy which we have de-
scribed previously [91.
Experimental protocols
Protocol 1. This protocol consisted of four separate periods
(control, sodium restriction, water restriction, post-control).
Six experiments were performed on five dogs (average wt =
18.8 1.1 kg) (as one dog underwent the protocol on two
separate occasions, four weeks apart). During the seven day
control period, the dogs were fed a daily diet containing 45 mEq
Na and 56 mEq K (Prescription Diet, canned H/D, Hills
Riviana, plus NaCI supplement). During this period, water was
available on an ad libitum basis. Following this control period,
the dogs were placed on a dry low Na chow (350 glday,
Prescription Diet, dry H/D, Hills Riviana) containing 6 mEq
Na and 63 mEq K for 12 to 15 days. During this sodium
restriction period, water was again freely available.
The present study reports on the results of a three day period
in which water was restricted to only that which was contained
in the low Na diet (approximately 35 mliter/day). It is impor-
tant to note that the feeding of the low sodium chow was
continued during both the water restriction and post-control
periods. Following the water restriction period, water was
returned on an ad libitum basis and the dogs were monitored for
an additional three days. This period, therefore, serves as a
post-control to match the sodium restriction period prior to
water restriction.
Urine samples were collected throughout the protocol for
measurement of daily volume, Na and K concentration, and
osmolality. Plasma samples were collected each morning prior
to feeding (9:00 to 10:00 A.M.) during the final three days of the
control period, during the final three days of the sodium
restriction period, and daily during the water restriction and
post-control periods. A total of 17.0 mliter of blood was drawn
on each occasion for determination of plasma Na and K
concentration, plasma osmolality (POSM), plasma vasopressin
concentration (PAVP), plasma renin activity (PRA) and plasma
aldosterone concentration (PALDO). Mean arterial pressure
was recorded continuously 24 hr/day during the final three days
of both the control and Na restriction periods and daily during
the water restriction and post-control periods.
Protocol 2:food restriction. Since with dehydration (Protocol
I) the dogs were observed to slightly reduce their food intake,
a second group of four dogs (average wt = 16.5 0.2 kg)
underwent a food restriction protocol. As described above, the
dogs were first placed on a dry low Na chow (dry HID, 350
g/day) for a 12 day period. The intake of low Na chow was
then decreased over a three day period in a manner designed to
match the decrease in food intake observed with water restric-
tion in Protocol 1. Finally, a three day post-control period was
conducted during which full feeding (350 g dry H/D per day)
was resumed. Water was available on an ad libitum basis
throughout the protocol. Urine was collected daily throughout
this protocol for measurement of volume, Na concentration,
and K + concentration.
Protocol 3: controlled aldosterone group (N = 6: Average wt
= 17.4 0.5 kg). This protocol consisted of the same four
periods as employed in Protocol 1 (control, sodium restriction,
water restriction, post-control). The major distinction between
this protocol and Protocol I was that in this protocol a contin-
uous 24 hr/day i.v. infusion of aldosterone (6.0 pg/kg/day) was
delivered during the water restriction period. Based on previous
studies [10], this rate was calculated to maintain plasma aldos-
terone concentration at the sodium restricted level during the
three day water restriction period. Plasma and urine samples
were collected on an identical schedule as that employed in
Protocol 1. Mean arterial pressure was recorded continuously
24 hr/day during the final three days of both the control and
Na restriction period, and daily throughout the water restric-
tion and post-control periods.
Protocol 4: neurohypophysectomized group: (N = 6: average
wt = 18.1 0.9 kg). The protocol employed with this group
also consisted of four periods: sodium restriction (12 days),
post-neurohypophysectomy transition (two to four days), water
restriction (three days) and a post-control period (three days).
The dogs were first maintained on the dry low sodium diet (350
g/day, Prescription Diet, dry H/D, Hills Riviana) for at least 12
days prior to neurohypophysectomy. During this period, water
was available ad libitum. The dogs then underwent selective
neurohypophysectomy, as described above. An i.v. infusion of
arginine vasopressin (AVP; Sigma, St. Louis, Missouri, USA)
was begun immediately following surgery at a rate (16
pg/kg/mm; Harvard Infusion Pump Model 935) to maintain
normal plasma levels and to prevent washout of the medullary
osmotic gradient. This i.v. AVP infusion was continued 24
hr/day throughout the protocol. The dogs were given two to
four days of post-operative recovery (post-neurohypox transi-
tion) prior to the initiation of water restriction. During this time
the dogs were fed the dry low sodium diet and drinking water
was freely available. A three day water restriction period was
then conducted, as described above (Protocol 1). Finally,
during a three day post-control period, the dogs continued to
receive the low Na chow, but drinking was returned to an ad
libitum basis.
Urine and plasma samples were collected during the last
three days of the sodium restriction period and daily during the
remainder of the protocol. Monitoring of mean arterial pressure
was initiated three to four days prior to neurohypophysectomy
and was continued 24 hr/day thereafter.
Urinary balance determination
The dogs were housed in stainless steel metabolic cages
designed to our specifications (Suburban Surgical Corporation,
Inc., Wheeling, Illinois, USA). At the same time each day (9:00
A.M.), total 24 hr urine volume was measured and a sample was
taken. All urine which had been spontaneously voided plus that
which could be drained by means of the implanted bladder
catheter was collected. In addition, the bottom of the cage was
rinsed carefully with I liter of distilled water. The total amount
of Na excreted for that 24 hr period was then determined by
adding the amount of Na in the 1 liter rinse to the calculated
urinary sodium excretion.
Sodium and potassium balances were calculated as the
amount of electrolyte (Na or K) consumed each day minus
the amount lost in the urine during the ensuing 24 hr period.
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Na and K balances during steady—state periods (final three
days of both the control and sodium restriction periods) were
normalized to zero. The Na and K balances during the water
restriction and post—control periods were expressed as a change
from the average values observed during the last three days of
Na restriction which was defined as zero balance. This was
done in order to account for fecal losses of Na and K which
were not measured in the present study.
Chemical and radioimmunoassay analysis
Urine and plasma Na and K concentrations were deter-
mined by standard flame photometry (Model 1L443, Instrumen-
tation Laboratory, Lexington, Massachusetts, USA). Urine
osmolality was measured by freezing point depression (Preci-
sion Systems, Inc., Osmette A Dudbury, Massachusetts,
USA). Plasma osmolality was measured by vapor pressure
osmometry (Model 5 C, Wescor, Inc., Logan, Utah, USA).
Samples were routinely run in triplicate to ensure results within
0.4%. Using verified standards, frequent calibration checks
were made during any measurement period to verify the con-
sistent linearity and slope of the instrument. Plasma and urine
urea concentration were determined by a sensitive fluorometric
assay [II]. Plasma vasopressin concentration was determined
using antisera and radioimmunoassay procedures developed in
this laboratory and described previously [12]. Plasma renin
activity was analyzed by the method of Sealey and Laragh [13]
using angiotensin I antisera. Plasma aldosterone was extracted
with dichioromethane and radioimmunoassayed using a highly
specific antisera and 1251-labeled aldosterone.
Blood pressure measurement
Mean arterial pressure was recorded continuously 24 hr/day
throughout the studies using a computerized monitoring system
described previously [14], The data in these protocols were
stored on a computer disc for editing and reduction, using batch
processing which provided hourly averages, statistics, and
graphics.
Statistical analysis
All values in this study are expressed as mean SE. An
analysis of variance for repeated measures followed by a
contrast test utilizing the BMD statistical package for signifi-
cance was performed [IS]. For comparison between groups an
unpaired Student's t-test was performed. Changes were consid-
ered of statistical significance for a P value of less than 0,05.
Results
Protocol I: Control dogs
The effects of two weeks of dietary sodium restriction fol-
lowed by three days of water restriction on various urinary
excretion parameters is shown in Figure 1. With dietary sodium
restriction, urine flow tended to decrease on the average 120
mliter/day by the end of the low sodium period, but this did not
reach statistical significance. During the final three days of this
sodium restriction period, Na excretion averaged 3.15 0.64
mEq/day. The dogs lost a total of 35.7 9.1 mEq of Na
during this two week period, with most of this (85%) occurring
during the first two days. Potassium excretion tended to in-
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crease with sodium restriction, but was not significantly ele-
vated.
With water restriction, dogs demonstrated a significant in-
crease in urinary sodium excretion (P < 0.05 on days I and 2)
and a significant negative sodium balance on all three days of
water restriction compared to the levels observed during the
final three days of the sodium restriction period. This natriure-
sis resulted in the net cumulative loss of 26.3 2.6 mEq of
sodium over the three day water restriction period. A significant
increase in K excretion and a significant negative potassium
balance (again compared to the final three days of the sodium
restriction period), was observed on day 2 of water restriction.
In addition, there was a strong tendency toward a negative K
balance on all three days of water restriction. This resulted in
the average net cumulative loss of5l.8 12.5 mEq ofK over
the three day dehydration period. Food intake was observed to
decrease only slightly during water restriction as intake aver-
aged 80.3, 92.6, and 70.6% of the control intake on days 1, 2,
and 3, respectively.
The hormonal changes associated with the renal excretory
responses are shown in Figure 2. With Na restriction alone,
no change was observed in PAVP (1.4 0.1 vs. 1,7 0.1
pg/mliter) while PRA increased from 1.28 0.16 to 2.66 0.17
if I I I10 12 13 15 +1 +3
Time, days
Fig. II. Urinary water and electrolyte (Na and K) excretory re-
sponses during each of the four periods of the water restriction
protocol. Asterisks represent statistically significant changes from the
Na* restricted state (P < 0.05). Crosses represent statistically signifi-
cant changes from the control state (P < 0.05, N = 6).
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Fig. 2. Plasma A VP (PA VP), plasma renin activity (PRA), plasma
aldosterone (PALDO) concentration and mean arterial pressure (MAP)
responses during the water restriction protocol. Asterisks represent
statistically significant changes from the Na restricted state (P <
0.05). Crosses represnt statistically significant changes from the control
state (P < 0.05, N = 6).
ng Al/muter/hr (P < .05) and PALDO increased from 7.1 1.1
to 24.9 3.1 ng/dliter (P < .05). With water restriction, plasma
AVP rose progressively from an average Na restriction level
of 1.7 0.1 pg/mliter to a peak level of 10.2 0.7 pg/mliter on
day three (a 6.5-fold elevation). PRA remained elevated at the
Na restriction level on days 1 and 2 of water deprivation and
rose to a significantly higher level on day 3. Plasma aldosterone
concentration, on the other hand, fell significantly (P < 0.05)
from the average levels of 24.9 3.1 ngldliter seen during the
final three days of Na restriction alone.
MAP averaged 110.7 3.1 mm Hg during the control Na
replete period (Fig. 2). No change in arterial pressure was
observed with either Na restriction or water restriction.
Plasma electrolyte, plasma osmolality, and urine osmolality
responses to Na restriction and water restriction are shown in
Table 1. Plasma Na concentration rose steadily from the
average Na restriction level of 143.6 0.3 mEq/liter to a level
averaging 152.7 1.0 on day 3 of water restriction (P < 0.05).
Plasma osmolality increased from a sodium restriction level of
297.9 1.2 to a peak of 322.1 4.1 with water restriction. In
contrast, plasma K concentration decreased by 0.2 to 0.3
mEq/liter (P < 0.05) on day 1 of water restriction from an
average sodium restriction level of 4.31 .07 mEq/liter.
Associated with the decrease in urine flow observed with water
restriction, urine osmolality (Uosm), increased significantly from
the levels observed with sodium restriction alone. Uosm aver-
aged 1162.1 79.9 mOsm/liter during the final three days of the
Na restriction period and rose to an average level of 1787.6
98.8 mOsmlliter during water restriction. No significant change
in either osmolar or free water clearance was observed through-
out the protocol.
Protocol 2: Food restriction
Food was restricted to an amount comparable in magnitude
to that observed in the control dogs (Protocol 1) during the three
days of water restriction. Accordingly, food intake was de-
creased to 80.3, 92.6 and 70.6% of the control intake on three
respective days following 12 days of a low Na intake. No
significant change in Na excretion was observed with food
deprivation, but a slight, yet significant negative balance was
observed on day 3. This negative Na balance resulted in the
net cumulative loss of 1.8 0.1 mEq during the three day food
restriction period compared to the loss of 26.3 2.6 mEq
during the three day water deprivation period. There was a
tendency toward a negative K balance which resulted in the
net cumulative loss of 13.9 6.9 mEq of K + over the three day
food deprivation period, but the change in K excretion or
balance did not reach statistical significance.
Protocol 3: Controlled aldosterone group
Figure 3 summarizes the hormonal and systemic arterial
pressure changes in each of the four periods of the protocol.
Plasma AVP (PAVP) concentration averaged 3.3 0.8
pg/mliter during the control sodium repletion period and re-
mained unchanged with 12 to 14 days of dietary sodium
restriction. With water restriction, PAVP increased progres-
sively and significantly up to a peak level of 14.95 1.9
pglmliter by day 3. Upon rehydration, PAVP was no longer
different from control, averaging 2.9 0.6 pglmliter over the
three days post-control period. Plasma aldosterone (PALDO)
concentration averaged 4.4 1.3 ng/dliter during the sodium
replete period and was increased significantly to levels averag-
ing 35.1 7.6 ngldliter during the last three days of the sodium
restriction period. Aldosterone was infused continuously during
the water restriction period to prevent the decrease of plasma
levels which we observed in Protocol 1. With these infusions,
plasma aldosterone was not significantly altered during either
the water restriction or post-control periods. Plasma renin
activity (PRA) averaged 1.11 0.33 during the control sodium
replete period and increased significnatly to levels averaging
3.86 1.19 ngAI/mliter/hr during the final three days of the
sodium restriction period. Like PALDO, PRA also remained
unchanged from the sodium restriction level during the water
restriction period. The 24 hr mean arterial pressures (MAP)
averaged 96.8 3.0 and 99.1 2.3 mm Hg during the control
and Na restriction periods, respectively. The average daily
pressure remained unchanged from these levels except for a
slight yet significant fall on day 1 of water restriction to a level
of 95.9 3.1 mm Hg.
Figure 4 summarizes the renal excretory responses (Na,
K, volume) during the four periods of the protocol. The most
striking result was that, in the absence of a decrease of PALDO,
no increase in sodium excretion was observed during three days
of water restriction. A significant net negative K + balance on
days 2 and 3 of water restriction and significant K + retention
upon rehydration was observed, however. Daily urine volume
decreased from control levels of 408.9 31.6 mliter/day to
levels averaging 277.5 29.4 mliter/day during the final 3 days
Post
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Fig. 3. Plasma vasopressin (PAv) plasma aldosterone (ALDO),
plasma renin activity (PRA), and mean arterial pressure (MAP) mea-
surements during each of the 4 periods of protocol 3 in which aldos-
terone (ALDO) was infused during the period of water restriction.
Crosses represent significant changes from the control sodium replete
level (P < 0.05). Asterisks indicate significant change from the sodium
restriction level (P < 0.05).
of Na restriction (P < 0.05). As expected, with water restric-
tion, urine excretion was observed to decrease progressively.
The values for plasma sodium concentration (PNa), plasma
potassium concentration (PK), plasma osmolality (Posm), urine
osmolality (Uosm), free water clearance (CH,o) and osmolar
clearance (Csm) are presented in Table 2. PNa decreased
slightly, yet significantly, from a control level of 145.8 0.9 to
a level averaging 143 0.9 mEq/liter during the final three days
of sodium restriction. PK, on the other hand, increased signifi-
cantly from an average value of 4.22 0.09 mEq/liter to levels
averaging 4.58 0.09 mEq/liter during the final three days of
sodium restriction. Osm averaged 292 1.6 mOsm/kg during
the control period and did not change with sodium restriction.
With water restriction, PNa and POsm increased progressively to
peak levels averaging 153.0 1.9 mEq/liter and 316.3 4.5
mOsm/liter, respectively. PK, on the other hand, decreased
Control
II
—10]
90
60
30 •
I
-
-1_____ - —±
:Ij J1L iu_
.
-w_- i____
Fig. 4. Urinary volume and electrolyte excretion responses during the 4
periods of protocol 3 in which aldosterone (ALDO) was infused during
water restriction. Crosses represent significant changes from the con-
trol sodium replete level (P < 0.05). Asterisks indicate significant
changes from the sodium restriction level. (P < 0.05).
significantly on days I and 3 of water deprivation. No change
was observed in either free water clearance or osmolar clear-
ance throughout the protocol. Uosm increased slightly with
sodium restriction and increased progressively with water re-
striction. Food intake during water restriction averaged 96%,
68%, and 73% of the control intake in this group of dogs (similar
in magnitude to that observed in protocols I and 2).
Protocol 4: Neurohypophysectomized dogs
Figure 5 summarizes the hormonal and systemic arterial
pressure changes in each of the four periods of this protocol.
PAVP averaged 4.2 0.7 pg/mliter during the sodium restric-
tion period and was maintained at this level after the
neurohypophysectomy by means of a continuous 24 hr/day i.v.
infusion of AVP at a rate of 16 pg/kg/mm. During the first two
days of water restriction, PAVP remained unchanged. On the
Days
Table 1. Urine osmolality, daily osmolar clearance, plasma electrolyte and osmolality responses during each of the four periods of Protocol 1
(normal dogs)
Control Sodium restricted Water restricted Post-control
—2 —l 0 12 13 14 15 16 17 +1 +2 +3
Uom 819.6 868.9 841.8 l068.4 1165.6 1252.3t 1559.2* 1924.2* 1879.3* 1128.3 1106.2 970.7
mOsm/liter 199.7 150.3 108.0
Com 0.91 1.02 0.98 1.27 1.06 0.80 0.80 1.19 1.01 0.82 0.85 1.15
mliter/min ±.09 ±03 ±.03 ±04 ±.15 ±40 ±02 ±10 ±.41 ±.16 ±.20 ±12
CH2O —.57 —.68 —.63 —.91 —.76 —.58 —.64 —1.00 —.83 —.61 —.55 —.81
muter/mm ±.03 ±04 ±.05 ±05 ±.l0 ±29 ±.03 ±09 ±.33 ±.l7 ±.05 ±10
143.8 143.6 144.2 143.0 143.8 143.9 147.6* 150.7* 152.7* 1381* 139.5* 140.9*
mEqlliter ±0.3 ±0.5 ±0.5 ±0.7 ±0.4 ±0.5 ±0.5 ±0.2 ± 1.0 ± 1.2 ±0.5 ±0.4
4.28 4.35 4.42 4.45 4.22 4.25 4.01* 4.14 4.13 4.54 4.50 4.44
mEqiliter ±0.8 ±08 ±.l2 ±11 ±.l7 ±.07 ±.09 ±13 ±.08 ±.18 ±.07 ±.07
PO,m 294.3 295.8 294.1 297.9 297.9 298.0 304.2* 313.6* 322.1* 290.5* 290.7* 291.6*
mEqlliter ±1.3 ±2.1 ±1.5 ±2.0 ±1.4 ±2.8 ±2.4 ±2.6 ±4.1 ±2.5 ±1.8 ±1.4
* Significant change (P < 0.05) from sodium restriction level.
Significant change (P < 0.05) from control level.
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Table 2. Urine osmolality, daily osmolar and free water clearance, plasma electrolytes, and osmolality responses during each of the four
periods of Protocol 3 (controlled aldosterone)
Control Sodium restricted Water restricted Post-control
Days —2 —I 0 12 13 14 15 16 17 +1 +2 +3
Uosm 839.0 902.1 915.8 1166.7* 1353.8 l266.O 1392.9* 1747.4* 1838.5* 1047.3 1193.7 1330.0
(±82.4) (±65.2) (±80.3) (±89.8) (±50.0) (±77.8) (±50.2) (±94.8) (± 102.4) (±83.0) (±70.1) (± 129.5)
Cosm 0.90 0.84 0.72 0.82 0.81 0.86 0.70 0.76 0.64 0.59 0.82 0.85
(±.06) (±.02) (±,04) (±.17) (±.ll) (±.16) (±07) (±.l1) (±.04) (±07) (±08) (±.ll)
C20 —.58 —.55 —.48 —.62 —.64 —.65 —.54 —.63 —.53 —.44 —.63 —.64(±.07) (±02) (±.03) (±.15) (±.08) (±.12) (±.06) (±.lO) (±03) (±.06) (±.07) (±10)
PNa 146.7 146.0 144.8 l44.O 142.3 l43.t 148.9* 150.5* 153.0* 140.3 141.0 142.1
(±0.9) (±1.0) (±0.9) (±0.9) (±1.3) (±0.4) (±0.9) (±2.3) (±1.9) (±1.1) (±1.2) (±0.8)
PK 4.28 4.26 4.11 'l.44 4.60 4.71t 4.46 3,93* 4.68 4.56 4.60
(±.12) (±.06) (±.08) (±.08) (±.07) (±.lI) (±.10) (±.07) (±.10) (±.l7) (±.08) (±.10)
Posm 293.5 291.0 294.3 291.8 291.5 293.5 306.3* 314.0* 316.3* 287.8* 290.3* 292.3*
(±2.2) (±1.6) (±1.0) (±2.3) (±1.2) (±1.6) (±2.1) (±4.4) (±4.5) (±1.9) (±1.1) (±1.6)
* Significant change (P C 0.05) from sodium restriction level.
Significant change (P C 0.05) from control level.
third day of water restriction, two of the six dogs exhibited large
increases in PAVP while the other four dogs exhibited little or
no change in PAVP. Therefore, the mean value for the group
was 16.2 7.2 pg/mliter on day 3, but this was not statistically
significant. PRA and PALDO averaged 5.21 1.10
ngAI/mliter/hr and 30.3 4.8 ngldliter respectively during the
final three days of the sodium restriction period and remained
unchanged post-neurohypophysectomy. With water restriction,
PRA progressively increased to a peak level of 13.44 3.55
ngAltmliterlhr by the third day. PALDO, on the other hand,
remained unchanged on days I and 2 of water restriction but
decreased significantly by day 3 (P C 0.05 compared to the
post-neurohypophysectomy level). Mean 24 hr arterial pressure
averaged 99.5 3.9 mm Hg during the sodium restriction
period and did not change significantly throughout the protocol.
During the rehydration period, daily pressure tended to de-
crease but reached a statistically lower value only on day 2.
Figure 6 summarizes the renal excretory responses during the
various periods of the protocol. Urinary sodium excretion
(UNAV) averaged 2.2 0.7 mEq/day during the sodium
restriction period and remained unchanged both after neurohy-
pophysectomy and during the three day water restriction pe-
riod. We did, however, observe a slight (—2.8 1.0) yet
significant negative sodium balance on day 2 of water restric-
tion. Urinary potassium excretion (UKV) averaged 46.4 7,1
mEq/day during the sodium restriction period and remained
unchanged after neurohypophysectomy. UKV tended to de-
crease with water restriction and was significantly decreased by
the third day. This, however, reflected a decrease in K intake
which was secondary to a decrease in food intake during water
deprivation in this group of dogs. Food intake did not decrease
post-surgically, but did decrease to 92, 49, and 38% of the
control sodium deplete intake on days 1, 2, and 3 of water
restriction, respectively. The K balance, on the other hand,
tended to be negative during this period but was statistically
significant only on day 2. Urine volume (UV) averaged 302.8
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Fig. 5. Plasma vasopressin (PA VP), plasma aldosterone (PALDO),
plasma renin activity (PRA), and mean arterial pressure (MAP) mea-
surements during each of the four periods of protocol 4 in
neurohypophysectomized dogs. Asterisks indicate significant changes
from the post neurohypophysectomy transition level (P C 0.05).
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Fig. 6. Influence of dietary sodium restriction, neurohypophysectomy,
and water restriction on urinary volume and electrolyte excretion
(Protocol 4). Asterisks indicate significant changes from the post-
neurohypophysectomy transition level (P C 0.05).
* Significant change (P < 0.05) from post neurohypox recovery level.
71.0 muter/day during the final three days of the sodium
restriction period and, despite normalized plasma AVP concen-
tration, increased after neurohypophysectomy to a level of
723.3 183.8 mliter/day. With water restriction, UV progres-
sively decreased and was significantly reduced on day 3 aver-
aging 237.5 40.1 muter/day.
The values for PNa, PK, Osm, Uosm, CH,O, and COsm during
each of the periods of the protocol are presented in Table 3
Neither PNa, PK, or POsm changed from the sodium restriction
level after neurohypophysectomy was performed. With water
restriction, however, both PNa and POsm increased significantly.
PK, on the other hand, was slightly elevated only on day I of
water restriction. No systematic changes in either free water or
osmolar clearance were observed. Urine osmolality decreased
after neurohypophysectomy to levels 1/2 to 1/3 those observed
during sodium restriction, despite the fact that PAVP remained
unchanged. With 24 hr of water restriction, urine osmolality
remained unchanged from the post-neurohypophysectomy level
but increased significantly on the 2nd and 3rd days.
Extent of stress associated with water restriction
As reported, the dogs ate quite well during the three days of
water restriction. Furthermore, and importantly, the slight
decrease in food intake observed during water restriction was
apparently not due to an inability to eat, for the dogs consumed
all their food immediately after water was returned. None of the
dogs exhibited signs of gastrointestinal distress (vomiting, diar-
rhea, etc.) upon rehydration. The dogs, in fact, exhibited none
of the classical symptoms of severe dehydration such as stupor,
disorientation, or lethargy. This is not surprising since extra-
cellular osmolality rose slowly and ranged between 315 to 325
mOsm/kg, and plasma Na concentration did not rise above
156 mEq/liter.
Hematocrit (Hct) measured in three of the dogs averaged 34.9
1,3% during the sodium restriction period and rose to levels
averaging 38.0 1.0% on day 2 of water restriction.
Plasma cortisol concentration, measured in two additional
dogs, rose only slightly from a sodium restriction level of 1.7
0.3 to 3.25 0.3 sg/dliter on day 3 of water restriction,
indicating relatively little stress to the animals.
Discussion
The increase in Na excretion which occurs with water
restriction has been described in a variety of species [1—7]. In
none of these previous studies have all the known major
controllers of Na excretion been carefully measured, thus it
has been difficult to elucidate the factor(s) responsible for this
dehydration natriuresis. In addition, the relative potency of the
factor(s) responsible for this increase in Na excretion have not
been assessed. In the present studies, the major factors known
to control Na excretion, including renal arterial perfusion
pressure, were sequentially determined from the onset of
chronic water restriction. With water restriction (Protocol I), a
significant increase in sodium excretion and a significant net
negative sodium balance were observed, even in the chronically
sodium deprived state. Normal water restriction, therefore,
appears to stimulate mechanisms which can override the nor-
mal homeostatic controls of total body sodium. This natriuresis
was accompanied by a significant rise in plasma AVP and a
significant fall in plasma aldosterone concentration. This natri-
uresis conceivably could have been caused by either of these
hormonal changes.
AVP has been observed to have natriuretic actions when
acutely infused intravenously into conscious animals [16].
Chronic administration of AVP and chronic excess endogenous
release (SIADH) are both clearly associated with substantial
loss of total body sodium [16, 17]. Both the acute and chronic
studies have been generally complicated by volume expansion
and elevations in mean arterial pressure. In studies in which
attempts were made to control the volume expansion (by a
reduction in fluid intake), no natriuresis was observed [181. In
another study recently carried out in our laboratory with dogs
maintained on a normal Na intake, we could find little
evidence for a direct chronic influence of plasma AVP on renal
Na excretion. In these studies in which volume expansion
during AVP infusion was prevented using a servo-controlled
water infusion device, a net loss of sodium ( —20 mEq) occurred
only during the first day of AVP administration [191.
The present studies demonstrate that when plasma aldoster-
one was prevented from falling during water restriction, no
Sodium restricted
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Table 3. Urine osmolality, daily osmolar and free water clearance, plasma electrolyte and osmolality responses during each of the four periods
of Protocol 4 (neurohypox dogs)
Post neurohypox
recovery Water restricted
5 6 7
Post-control
+1 +2 +3Days —2 —1 0 4
795.5Uom 1359.4 1273.8 1152.1 539.0 699.6 1297.6* 1258.0* 817.7 813.9
(±222.2) (±207.9) (±218.0) (± 146.2) (±76.2) (±219.7) (±211.1) (± 103.8) (± 126.9) (± 142.3)
Cosm 0.75 0.68 0.78 0.84 0.77 0.64* 0.59 0.59 0.95 0.92
(±.07) (±05) (±.07) (±12) (±.10) (±.08) (±.02) (±03) (±.l0) (±.I0)
CH2O — .56 — .48 — .53 — .29 — .42 — .46 — .42 — .37 — .57 — .53(±.09) (±06) (±.07) (±.13) (±.08) (±.09) (±.04) (±05) (±08) (±.08)
PNa 144.9 145.2 142.6 142.9 151.6* 155.0* 156.0* 139.1 139.9 140.3
(±0.5) (±0.3) (±0.9) (±1.1) (±1.6) (±1.8) (±2.1) (±1.0) (±1.1) (±1.1)
PK 4.80 4.69 4.58 4.53 4,73* 4.41 4.50 4.83 4.77 5.00
(±.15) (±10) (±07) (±.lO) (±06) (±.l5) (±.20) (±.29) (±30) (±27)
Posm 302.0 299.8 297.8 295.6 314.8* 317.9* 324.2* 290.2 287.0* 289.9
(±2.1) (±2.4) (± 1.1) (±2.3) (±4.4) (±6.4) (±7.0) (±3.0) (±4.2) (±2.7)
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Fig. 7. Summary of urinary sodium excretion (UNaV) responses during
three days of water restriction in 3 groups of sodium restricted dogs:
intact dogs (D, Protocol I—Control); intact dogs in which PALDO was
held constant during water restriction (, Protocol 3-Controlled
ALDO); and neurohypophysectomized dogs (c, Protocol 4—Neurohy-
poxy). Asterisks represent significant difference between means SEM
(P < 0.05).
increase in sodium excretion occurred. These data indicate that
the natriuresis which we observed with water restriction in
sodium restricted dogs was secondary to the fall in aldosterone
and not the rise in vasopressin concentration.
Interestingly, we were also able to prevent the natriuresis by
performing a selective neurohypophysectomy on the sodium
restricted dogs prior to water restriction. In this group of dogs
the rise in plasma vasopressin during water restriction was
prevented. These studies first appeared to lend credence to a
role for AVP in the natriuretic response. We do not believe,
however, that this was the case since in this group of dogs,
plasma aldosterone (PALDO) never fell significantly below the
sodium restriction level, whereas in our intact sodium restricted
dogs PALDO fell from a level of 24.9 5.6 to levels averaging
12.4 2.7 ng/dliter with water deprivation. Thus, the only
hormonal change that we measured that was consistently asso-
ciated with a natriuresis was a decrease in plasma aldosteronc.
(The sodium excretory responses of these three groups is
summarized in Figure 7).
One could possibly hypothesize that the fall in aldosterone
with water restriction might not result in an increase in sodium
excretion due to the fact that after two weeks of dietary sodium
restriction, the distal tubule may already have "escaped" from
the sodium retaining effects. Recent studies by Hall, Granger,
and Premen [20] and Kohan and Knox [21], however, argue
strongly against any "escape" at the distal tubular level. During
water restriction, however, aldosterone would presumably still
be acting to retain sodium. A 50% reduction in plasma aldos-
terone concentration, as was seen with water restriction, would
logically result in a reduction of tubular Na reabsorption.
Additional support for this hypothesis stems from studies by
Childers and Schneider [22]. They observed that in sodium
deplete dogs, the cumulative sodium excretion after a given
sodium load (2.5 mM) was greater if the load was given as a
hypertonic infusion rather than a hypotonic infusion and that
plasma aldosterone concentration was significantly lower after
the hypertonic infusions. Finally, these differences were not
observed in sodium deplete dogs which were treated with
deoxycorticosterone acetate, a potent mineralocorticoid, prior
to the infusions. These results suggest that decreases in plasma
aldosterone, similar in magnitude to that which we observed
with water restriction, can result in increases in sodium excretion.
It should be pointed out that with water restriction we also
observed significant urinary potassium loss. A kaliuresis would
not be expected to accompany a decrease in plasma aldosterone
concentration. Considering known Na/K ATPase actions of
aldosterone, one would predict a decrease, rather than an
increase, in K excretion in response to a decrease in PALDO.
The mechanism responsible for the observed kaliuresis is not
clear, but does not appear to be due to the rise in PAVP, for we
observed a negative potassium balance with water restriction in
the neurohypophysectomized dog.
The fall in plasma aldosterone with dehydration has not been
a consistent observation in all species studied. Zucker,
Gleason, and Schneider [6] observed a decrease in urinary
aldosterone excretion but no change in plasma aldosterone with
water restriction in sodium replete dogs. Similarly, Thrasher et
al [I] observed a natriuresis with no change in plasma aldoster-
one with 24 hr of water deprivation in the Na replete dog.
Blair—West, Brook, and Simpson [23] and El—Nouty et al [24]
observed a suppression of aldosterone with dehydration in
sheep and cattle, respectively. Lucke et al [3], however, found
in rats that plasma aldosterone increased with water restriction,
yet a negative sodium balance was observed. Similarly,
McKenna and Haines [4] observed a natriuresis in water
restricted mice with little change or increases in urinary aldos-
terone excretion. Finally, the aldosterone response to water
restriction in camels [25, 26] appeared to vary with seasonal
conditions. An explanation for these discrepancies is not
readily apparent, but may involve differences in sodium intake
(and hence, differences in baseline PALDO levels) and/or
differences in the extent of water restriction imposed.
Natriuretic potency of AVP
These studies also address the question as to the relative
potency of AVP as a natriuretic agent. In the present studies,
despite the fact that plasma AVP rose from 3.2 0.8 to a peak
level of 14.9 1.9 pg/mliter when plasma aldosterone was
prevented from decreasing with water restriction (Protocol 3),
the dogs failed to demonstrate a natriuresis. We conclude from
these and other studies already cited [19] that AVP has minimal
chronic effects on renal sodium excretion independent of
known controllers.
Mechanism for fall in PALDO with water restriction
The mechanism for the fall in plasma aldosterone which we
observed in normal Na restricted dogs remains unclear. This
decrease of aldosterone was especially intriguing since PRA
remained unchanged or increased with water restriction.
This dissociation of plasma aldosterone concentration from
PRA may simply be due to alterations of plasma electrolytes
and/or changes in adrenal sensitivity to these alterations.
Plasma K concentration, a potent controller of aldosterone
secretion, was observed to fall slightly (0.2 to 0.3 mEq/liter)
with water restriction. Although this small change in plasma K +
normally would not account for the large drop in aldosterone
concentration [27], it has recently been reported that elevation
of angiotensin II may enhance the actions of K on aldosterone
secretion [28]. Furthermore, pharmacological blockade of angi-
otensin II formation (Captopril) has been shown to severely
blunt the aldosterone response to changes in plasma K [29,
30]. Therefore, in the sodium deprived dog (high All state),
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extremely small changes in plasma K may significantly alter
plasma aldosterone.
Changes in plasma sodium concentration which normally are
not thought to be potent controllers of aldosterone secretion
[31—33] may also have contributed to the fall in aldosterone
concentration either through peripheral or central actions.
Abraham et al [34] observed in sheep that short—term (9 hr)
elevations of CSF Na from 145 to 170 mEq/liter significantly
reduced plasma aldosterone concentration. This suppression of
PALDO could not be acounted for by changes in plasma Na,
K, or PRA. Interestingly, McKinley et al, [35] were able to
inhibit the dehydration natriuresis in sheep by decreasing the
cerebrospinal fluid NaCI concentration through intraventricular
infusions. Finally, the adrenal may be more sensitive to changes
in plasma sodium concentration in high angiotensin II states
such as Na restriction. Blair—West et al [36] observed that
elevations of plasma Na4 from 8 to 13 mEq/liter could acutely
decrease the excess aldosterone secretion observed after angi-
otensin II administration. Recently, Schneider et al have re-
ported that small (4 to 7 mEq/liter) elevations in sodium
concentration markedly reduced aldosterone secretion in the
angiotensin II stimulated isolated adrenal gland [37]. The direct
effect of physiological changes of plasma AVP on adrenal
secretion of aldosterone are unclear, Although AVP has been
shown to have ACTH stimulating effects [38], chronic infusion
of vasopressin has not been associated with any clear change in
plasma aldosterone [18, 19] when fluid retention was presented.
Excess secretion of prostaglandin E2 by the kidney has also
been observed during water restriction [39]. The extent to
which prostaglandins may mediate the decrease in aldosterone
is not clear, but infusions of PGE1 directly into the sheep
adrenal glands produced no systematic effect on aldosterone
secretion rate [40].
Other factors proposed to regulate aldosterone secretion
include epinephrine [41], norepinephrine [41], dopamine [42]
and atrial natriuretic factor (ANF) [43]. ANF has been shown to
acutely decrease aldosterone [43]. Interestingly, AVP has re-
cently been shown to stimulate ANF release. This effect does
not happen to be specific for AVP, however, but rather happens
to be associated with the rise in arterial pressure which was
observed [44]. The physiological importance of ANF in the
normal control of aldosterone secretion has yet to be clearly
established.
In summary, these studies clearly demonstrate that a natri-
uresis occurs with water restriction even in the chronically
sodium deprived state. We conclude from these studies that the
observed natriuresis with water restriction in sodium deprived
dogs was most likely due to an unexplained fall in plasma
aldosterone concentration, and not to elevations in plasma
AVP. The mechanism for the apparent dissociation of plasma
aldosterone from PRA during the water restriction is not clear
but may involve a combination of plasma electrolyte changes.
The other major finding of the present study was the remarkable
ability of these dogs to withstand the prolonged water restric-
tion with seemingly minimal stress. It appears that the natriure-
sis, combined with the decrease in solute intake afforded
important protection against more serious cellular dehydration.
This finding has important clinical relevance for elderly and
comatose patients who many times cannot or do not respond
appropriately to thirst stimuli. These patients, who many times
are maintained through hyperalimentation, tend toward
hypernatremic dehydration states [45, 46]. The present study
indicates that careful monitoring of sodium intake could signif-
icantly diminish the severity of the dehydration.
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